<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01999751</url>
  </required_header>
  <id_info>
    <org_study_id>EH12274</org_study_id>
    <nct_id>NCT01999751</nct_id>
  </id_info>
  <brief_title>Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans</brief_title>
  <official_title>SMDC CRM-MRI Prospective Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Essentia Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Essentia Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, non-randomized, unblinded case series of patients with permanent
      pacemakers and implantable cardioverter-defibrillators undergoing medically-required magnetic
      resonance imaging (MRI) scanning, at St. Mary's Medical Center, Essentia Health. Patients
      will be enrolled over a 60-month period and followed for 12 months, with data collected to
      evaluate the study's primary endpoint, change in pacing thresholds over time, as well as a
      series of secondary endpoints, including: adverse events, symptoms, need to make pacemaker
      programming changes, and possible artifacts created by the pacemaker systems on the MRI
      scans. This study will allow for carefully monitoring of the safety MRI scanning in this
      population and improve practice models and protocols in the future.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      General Approach: This study is a prospective, non-randomized, unblinded case series of
      patients with permanent pacemakers or implantable cardioverter-defibrillators (ICDs)
      undergoing medically-required MRI scanning, followed for a 12 month period. MRI scanning will
      be performed using accepted, standard protocols using FDA-approved equipment.

      Methods and Materials: Patients will be enrolled over a 60-month period by the Principal
      Investigator (PI) and/or Sub-Investigator (Sub-I), at the Regional Heart Center, located at
      St. Mary's Medical Center, Essentia Health, Duluth, MN, during evaluations for
      medically-required MRI scanning. Eligible patients includes any person with a permanent
      pacemaker or ICD implanted for at least 6 weeks, referred for a medically-required MRI scan
      by a physician not participating in the trial. ICD generators must have been market released
      after 2001. Both pacemaker dependent and non-dependent patients are eligible. The primary
      endpoint is any change greater than 1 V at a pulse width of 0.5 ms in a pacemaker or ICD lead
      at any time within 12 months of the MRI scan.

      On the day of the MRI scan, the pacemaker or ICD will be interrogated and programmed per
      usual practice at Essentia Health for patients undergoing an MRI scan with device in place.
      Three separate baseline capture threshold measurements (V) will be obtained at a fixed pulse
      width of 0.5 msec. Three separate baseline measurements will also be made of lead pacing
      impedances (Ohms) and sensed P- or R-waves (mV) using programmer default methods. Histograms
      will be cleared. Leads will be programmed to bipolar modality. If the patient is not device
      dependent, the device will be programmed to ODO/OVO/OAO mode (monitor only) if available,
      otherwise it will be reprogrammed to DDI or VVI mode with a lower rate of 40 bpm with pacing
      outputs programmed to subthreshold levels in all leads. If the participant is device
      dependent, the device will be programmed to an asynchronous pacing modality (DOO/VOO) with
      maximum pacing output. If the patient has an ICD, therapies will be disabled. The attending
      investigator may alter the pacing modality during the course of the scan if he or she deems
      it necessary to maximize patient safety or comfort. Rate responsiveness, any rate
      enhancements including Ventricular Rate Regulation mode, and magnet mode will be turned off.

      During MRI scanning, resuscitation equipment will be available. If the participant is
      pacemaker dependent, the study PI or sub-I must be in the MRI suite during the scan. If the
      participant is not pacemaker dependent, then a pacemaker nurse will be in the MRI suite to
      perform pre- and post-checks, and an electrophysiologist will be available in the building
      for questions and troubleshooting. Patients will be asked to report all symptoms including:
      palpitations; pain; heat or warmth sensation; device movement; or light-headedness.

      Scans will be performed using usual protocols with standard peak Specific Absorption Rate
      (SAR) limitations for the scan. The MRI scans will be evaluated for any artifact created by
      the pacemaker system. During the scan, continuous electrocardiographic and pulse oxymetry
      with waveform monitoring will be performed using usual protocols. Following the scan, repeat
      thresholds will be performed for each lead and histograms will be obtained. Three separate
      capture threshold measurements (V) will be obtained immediately after the patient leaves the
      scanner room at a fixed pulse width of 0.5 msec. Three separate measurements will also be
      made immediately following the scan of the lead pacing impedances (Ohms) and sensed P- or
      R-waves (mV) using programmer default methods. Participants who are pacemaker dependent will
      undergo a one-hour post-scan check using the same threshold protocol. These one-hour post
      scan measurements will be performed either in the pacemaker clinic if the patient is an
      outpatient or in the hospital if the patient is an inpatient. Any stored events detected on
      the device as electromagnetic interference (EMI) artifact during the scan may be retrieved
      and stored to diskette for later analysis. The pacemaker or ICD will be reprogrammed to
      original settings prior to discharge from the MRI suite unless the attending investigator
      deems it necessary to alter device setting to maximize patient safety or comfort. If the
      patient has an ICD, the capacitor will be reformed and charge time noted prior to dismissal
      from the MRI suite.

      Patients will be followed up in the pacemaker clinic at 3 and 12 months from the MRI scan
      using usual clinic protocols for device follow-up. If a patient undergoes a second MRI scan,
      the follow-up schedule will be set based upon the most recent MRI scan.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">April 11, 2018</completion_date>
  <primary_completion_date type="Actual">April 2, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Pacing threshold increase</measure>
    <time_frame>12 months</time_frame>
    <description>Any change greater than 1 V at a pulse width of 0.5 msec in a pacemaker or implantable cardioverter-defibrillator lead at any time within 12 months of the MRI scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ectopy</measure>
    <time_frame>1 hour</time_frame>
    <description>Increased cardiac ectopy at the time of the MRI scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pacemaker reprogramming</measure>
    <time_frame>12 months</time_frame>
    <description>Unanticipated pacemaker or implantable cardioverter-defibrillator reprogramming because of alterations in device behavior possibly related to the MRI scan</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">124</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>MRI Scan</arm_group_label>
    <description>Patients with implantable cardioverter-defibrillator or pacemaker who undergo an MRI scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI Scan</intervention_name>
    <description>Clinically indicated MRI scan of patients with pacemaker or implantable cardioverter-defibrillator in situ.</description>
    <arm_group_label>MRI Scan</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any person followed at St. Mary's Medical Center, Duluth, MN, with a permanent pacemaker or
        implantable cardioverter-defibrillator implanted for at least 6 weeks, referred for a
        medically-required MRI scan by a physician or provider not participating in the trial. If
        patients elect not to participate, they may still receive an MRI and will sign the clinical
        consent. If they elect not to have an MRI, they will be referred back to the ordering
        provider to discuss other options.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Permanent Pacemaker or ICD implanted for at least 6 weeks

          2. Referred for medically-required MRI scan

          3. Age greater than or equal to 18 years

        Exclusion Criteria:

          1. ICD market released before 2001 including GDT Ventak-AV, GDT MINI-II, GDT MINI-IV, GDT
             MINI-III, GDT Prizm, GDT Prizm-2 and MDT GEM-I series

          2. Epicardial lead or subcutaneous array

          3. Device has reached elective replacement indicator (ERI) or end of life (EOL)

          4. Other usual contraindications to MRI scanning

          5. Known or suspected lead fracture or abandoned lead

          6. Pacemaker dependent patients with an ICD that cannot be programmed to asynchronous
             pacing (DOO/VOO)

          7. Clinical factors that are deemed by the PI or Sub-I to increase the participant's risk
             above an acceptable clinical threshold
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael E Mollerus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Essentia Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Mary's Medical Center</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55812</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol. 1987 Oct;10(4):782-6.</citation>
    <PMID>3655146</PMID>
  </reference>
  <reference>
    <citation>Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B; North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med. 2001 Mar 12;161(5):649-55. Review.</citation>
    <PMID>11231696</PMID>
  </reference>
  <reference>
    <citation>Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004 Apr 7;43(7):1315-24.</citation>
    <PMID>15063447</PMID>
  </reference>
  <reference>
    <citation>Erlebacher JA, Cahill PT, Pannizzo F, Knowles RJ. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol. 1986 Feb 15;57(6):437-40.</citation>
    <PMID>3946261</PMID>
  </reference>
  <reference>
    <citation>Fetter J, Aram G, Holmes DR Jr, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol. 1984 Jul;7(4):720-7.</citation>
    <PMID>6205375</PMID>
  </reference>
  <reference>
    <citation>Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Tr√§ber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology. 2000 Jun;215(3):869-79.</citation>
    <PMID>10831713</PMID>
  </reference>
  <reference>
    <citation>Shellock FG, O'Neil M, Ivans V, Kelly D, O'Connor M, Toay L, Crues JV. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system. AJR Am J Roentgenol. 1999 Jan;172(1):165-70.</citation>
    <PMID>9888762</PMID>
  </reference>
  <reference>
    <citation>Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004 Aug 3;110(5):475-82. Epub 2004 Jul 26.</citation>
    <PMID>15277324</PMID>
  </reference>
  <reference>
    <citation>Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006 Sep 19;114(12):1277-84. Epub 2006 Sep 11.</citation>
    <PMID>16966586</PMID>
  </reference>
  <reference>
    <citation>Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol. 2005 Apr;28(4):270-3.</citation>
    <PMID>15826257</PMID>
  </reference>
  <reference>
    <citation>Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace. 2010 Jul;12(7):947-51. doi: 10.1093/europace/euq092. Epub 2010 Mar 30.</citation>
    <PMID>20353963</PMID>
  </reference>
  <reference>
    <citation>Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.</citation>
    <PMID>21969340</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>December 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2013</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Essentia Health</investigator_affiliation>
    <investigator_full_name>Michael Mollerus</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Pacemaker, Artificial</keyword>
  <keyword>Defibrillators, Implantable</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

